NCT04646967View on ClinicalTrials.gov

An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

January 25, 2024

Study Completion Date

January 25, 2024

Conditions
Pain, PostoperativePhimosisParaphimosisBalanitis
Interventions
DRUG

Bupivacain

See active comparator description

DRUG

Sevoflurane

See active comparator description

DRUG

Acetaminophen

See active comparator description

DRUG

Ibuprofen

See active comparator description

DRUG

Ketorolac

See experimental arm description

Trial Locations (1)

T3B 6A8

Alberta Children's Hospital, Calgary

All Listed Sponsors
lead

Alberta Children's Hospital

OTHER